Relationship between Reductions in Parathyroid Hormone and Serum Phosphorus during the Management of Secondary Hyperparathyroidism with Calcimimetics in Hemodialysis Patients

Publisher： Karger

E-ISSN： 1660-2110|121|3-4|c124-c130

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.121, Iss.3-4, 2012-11, pp. : c124-c130

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

By  

THERAPEUTIC APHERESIS AND DIALYSIS, Vol. 19, Iss. 4, 2015-08 ,pp. : 367-377

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combination Therapy of Intravenous Maxacalcitol and Percutaneous Ethanol Injection Therapy Lowers Serum Parathyroid Hormone Level and Calcium × Phosphorus Product in Secondary Hyperparathyroidism

By  

Nephron Clin Pract, Vol. 102, Iss. 1, 2005-09 ,pp. : c1-c7

Karger

Access to resources Recommend Favorite

Serum parathyroid hormone and alkaline phosphatase as predictors of calcium requirements after total parathyroidectomy for hypocalcemia in secondary hyperparathyroidism

By  

HEAD & NECK: JOURNAL FOR THE SCIENCES & SPECIALTIES OF THE HEAD AND NECK, Vol. 40, Iss. 2, 2018-02 ,pp. : 324-329

John Wiley & Sons Inc

Access to resources Recommend Favorite

Management of serum calcium reductions among patients on hemodialysis following cinacalcet initiation

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 10, 2015-10 ,pp. : 1058-1067

John Wiley & Sons Inc

Access to resources Recommend Favorite

Management of serum calcium reductions among patients on hemodialysis following cinacalcet initiation

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 1053-8569, Iss. 10, 2015-10 ,pp. : 1058-1067

John Wiley & Sons Inc

Access to resources Recommend Favorite